SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-16-013173
Filing Date
2016-05-11
Accepted
2016-05-11 16:06:43
Documents
72
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0316_immucellcorp.htm 10-Q 516753
2 CERTIFICATION f10q0316ex31_immucellcorp.htm EX-31 8199
3 CERTIFICATION f10q0316ex32_immucellcorp.htm EX-32 3926
10 GRAPHIC image_001.gif GRAPHIC 9143
  Complete submission text file 0001213900-16-013173.txt   3416776

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE iccc-20160331.xml EX-101.INS 549933
5 XBRL SCHEMA FILE iccc-20160331.xsd EX-101.SCH 41799
6 XBRL CALCULATION FILE iccc-20160331_cal.xml EX-101.CAL 75696
7 XBRL DEFINITION FILE iccc-20160331_def.xml EX-101.DEF 73707
8 XBRL LABEL FILE iccc-20160331_lab.xml EX-101.LAB 368241
9 XBRL PRESENTATION FILE iccc-20160331_pre.xml EX-101.PRE 235491
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12934 | Film No.: 161639944
SIC: 2835 In Vitro & In Vivo Diagnostic Substances